- decreased bone mineral content / IMPC
- increased total body fat amount / IMPC
- decreased exploration in new environment / IMPC
- increased circulating fructosamine level / IMPC
- tremors / IMPC
- decreased lean body mass / IMPC
- decreased mean corpuscular volume / IMPC
- preweaning lethality, incomplete penetrance / IMPC
- increased circulating serum albumin level / IMPC
C57BL/6N-F2tm1a(EUCOMM)Hmgu/H
Status | Available to order |
EMMA ID | EM:07788 |
International strain name | C57BL/6N-F2tm1a(EUCOMM)Hmgu/H |
Alternative name | HEPD0720_4_G11 |
Strain type | Targeted Mutant Strains |
Allele/Transgene symbol | F2tm1a(EUCOMM)Hmgu |
Gene/Transgene symbol | F2 |
Disclaimer | Please note that for EUCOMM and KOMP-CSD mice supplied to the scientific community by INFRAFRONTIER/EMMA:
|
Information from provider
Provider | MRC, Medical Research Council |
Provider affiliation | Mary Lyon Centre at MRC Harwell |
Genetic information | This mouse line originates from EUCOMM ES clone HEPD0720_4_G11. For further details on the construction of this clone see the page at the IMPC portal. |
Phenotypic information | Potential phenotyping data in the IMPC portal |
References | None available |
Information from EMMA
Archiving centre | Mary Lyon Centre at MRC Harwell, Oxford, United Kingdom |
Disease and phenotype information
IMPC phenotypes (gene matching)
MGI phenotypes (gene matching)
- distended pericardium / MGI
- decreased embryo size / MGI
- abnormal visceral yolk sac morphology / MGI
- pale yolk sac / MGI
- embryonic growth arrest / MGI
- hemorrhage / MGI
- intracranial hemorrhage / MGI
- no abnormal phenotype detected / MGI
- abnormal blood coagulation / MGI
- abnormal vitelline vasculature morphology / MGI
- decreased susceptibility to induced arthritis / MGI
- pallor / MGI
- hemopericardium / MGI
- homeostasis/metabolism phenotype / MGI
- abnormal circulating protein level / MGI
- increased bleeding time / MGI
- decreased susceptibility to endotoxin shock / MGI
- decreased platelet aggregation / MGI
- lethality, incomplete penetrance / MGI
- postnatal lethality, complete penetrance / MGI
- neonatal lethality, complete penetrance / MGI
- embryonic lethality, incomplete penetrance / MGI
- embryonic lethality during organogenesis, incomplete penetrance / MGI
- lethality throughout fetal growth and development, incomplete penetrance / MGI
- purpura / MGI
- embryo tissue necrosis / MGI
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).